This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $497,245.96, is for the provision of Illumina's genomic sequencing services and related products, including sequencing instruments like NextSeq, NovaSeq, and MiSeq systems, along with associated reagents, consumables, maintenance, and technical support. The contract does not have a set-aside designation.
Illumina has been awarded multiple prime federal contracts and grants across various agencies, including the VA, National Institutes of Health, Centers for Disease Control and Prevention, and Food and Drug Administration, primarily for the procurement of its advanced genomic sequencing platforms and services. This contract appears to be part of the VA's efforts to leverage Illumina's technology for genomic research and diagnostic applications. The contract is also linked to two Illumina Indefinite Delivery Vehicles (IDVs) with the VA, valued at $231,165 and $1,297,062, respectively, which provide additional flexibility for the agency to order Illumina's products and services as needed.
Generated 6/13/25, 9:58 AM